跳至主要内容
临床试验/PACTR201812819039144
PACTR201812819039144招募中3 期

Evaluation of a nitric oxide generating dressing (EDX110) to improve management of Buruli ulcer disease (BURULINOX)

Kumasi Centre for Collaborative Research0 个研究点目标入组 142 人开始时间: 2018年12月18日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
142

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 Year(s) 至 12 Year(s)(—)
性别
All

入选标准

  • i.Male or female patients aged between 5 years and 80 years inclusive.
  • ii.Buruli lesion (ulcer, nodule or plaque) iii.The lesion must have been tested positive for M. ulcerans by PCR for IS2404
  • iv.Able to give informed consent/assent for minors.
  • v.Able and willing (or have parents/carers able and willing) to follow the protocol requirements

排除标准

  • i.Female patients who are pregnant or breast-feeding.
  • ii.Any other serious disease likely to compromise the outcome of the trial.
  • iii.Participation in any interventional study during the 2 weeks (or 5 half-lives of the investigational product, if longer) preceding the intervention period of the study.
  • iv.Currently taking antibiotics that could interact with the trial medication.
  • v.Known allergy to any of the oral antibiotics or components of EDX dressing

研究者

发起方
Kumasi Centre for Collaborative Research

相似试验